Ly6/urokinase-type plasminogen activator receptor (uPAR) (LU) domain containing 6 (LYPD6) is a Wnt signaling enhancer that promotes phosphorylation of the Wnt coreceptor low density lipoprotein receptor-related protein 6 (LRP6). It also binds the nicotinic acetylcholine receptor (nAChR). We report here the 1.25 A resolution structure of the LYPD6 extracellular LU domain and map its interaction with LRP6 by mutagenesis and surface plasmon resonance. The LYPD6 LU structure reveals a 'trifingered protein domain' fold with the middle fingertip bearing an 'NxI' motif, a tripeptide motif associated with LRP5/6 binding by Wnt inhibitors. Of the Ly6 protein family members, only LYPD6 has an NxI motif. Since mutations in the LYPD6 NxI motif abolish or severely reduce interaction with LRP6, our results indicate its key role in the interaction of LYPD6 with LRP6.
The Wnt signaling pathway is fundamental for animal embryonic development as well as adult tissue homeostasis and regeneration, conversely mis-regulation of Wnt signaling may contribute to diseases such as cancer or Alzheimer's disease [1] [2] [3] . To ensure Wnt signaling is finely tuned to the correct level at the right time and context, animals use a complex set of Wnt ligands, receptors, conductors, inhibitors, and enhancers [4] . On the animal cell surface, the core canonical Wnt signaling complex consists of Wnt ligands and receptors of the Frizzled (FZD) and Low density lipoprotein receptor-related protein 5/6 (LRP5/6) families. Many regulators modulate Wnt signaling through interaction with the core signaling ligands and receptors. Notum and Tiki enzymes modify the Wnt ligands [5, 6] ; the secreted frizzled related proteins and Wnt inhibitory factor 1 (WIF-1) prevent FZD receptors from binding to Wnts [4, 7] ; the secreted Dickkopf proteins (DKKs), sclerostin (SOST), or sclerostin domain-containing 1 (SOSTDC1/WISE) antagonize Wnt signaling by binding to the LRP5/6 extracellular domains [8] . For the LRP5/6 binding Wnt inhibitors, a tripeptide asparagine-x-isoleucine motif, the Nxl motif, has been functionally implicated in receptor binding and inhibition [8, 9] . Structures of the LRP6 PE1 [the first beta propeller plus epidermal growth factor (EGF)-like module of LRP6] in complex with NxI motif containing 7-mer peptide from DKK1 (PDB code 3SOQ) or SOST (PDB code 3SOV) have been determined [8] .
Recently, a lymphocyte antigen-6 and urokinasetype plasminogen activator receptor (uPAR) family member, Ly6/uPAR (LU) domain containing 6 (LYPD6), has been identified as a Wnt/b-catenin signaling enhancer that acts by extracellular binding to LRP6 promoting LRP6 phosphorylation [10] . LYPD6, and a closely related LU domain protein, LYPD6B (also named LYPD7) have also been reported to act as modulators of the nicotinic acetylcholine receptor (nAChR) [11, 12] . The LYPD6 LU is tethered to the cell surface by a GPI anchor. The ectodomain of LRP6 comprises four repeats of b-propeller domain plus EGF like module (PE1-PE4), followed by three LDLR type A domains leading to the single transmembrane helix and cytoplasmic region. Here we report details of the molecular interaction between LYPD6 and LRP6 revealed by the crystal structure of LYPD6 LU at 1. 25 A resolution and structure based mutagenesis combined with in vitro binding studies of LYPD6 LU to the LRP6 PE1PE2 , LRP6 PE3PE4 segments of the ectodomain of LRP6 (LRP6 ECD ).
Materials and methods

Protein production and crystallization
Human LYPD6 (UniProtKB/Swiss-Prot Q86Y78), residues G46-A141 was PCR amplified from the cDNA (Source Bioscience, Nottingham UK; clone ID 5171270) and cloned into a stable cell line vector pURD [13] with 3C and monoVenus fusion tag ended with 6xHis. The construct results in processed protein of sequence ET-G 
141
-GTLEVLFQ (the underlined sequences are from the cloning vector). HEK293S GnTI(À) cells [14] were cotransfected with a pURD-LYPD6 LU and a PhiC31 integrase expression vector (pCB92/pgk-φC31) [15] . The polyclonal population cells from puromycin (2 lgÁmL
À1
) selection were cultured in Hyperflasks (Corning, Deeside, Flintshire, UK) in a CompacT automated cell culture system [16] . The secreted proteins were captured by Talon Co 2+ affinity resin (Takara Bio Europe SAS, Saint-Germain-en-Laye, France) after the conditional media was dialyzed against PBS. The protein bound Talon beads were washed with 20 mM imidazole and eluted with 300 mM imidazole. The eluted protein was treated with 3C protease to remove the monoVenus-His tag and then deglycosylated using EndoF1 (HEK293S GnTIÀ cells generate mannose-rich glycans at N-linked glycosylation sites which are cleavable by EndoF1 to leave one NAG covalently attached to the asparagine). After reverse tag capture with Talon beads, the protein was subjected to Superdex 200 16/60 column size exclusion chromatography and concentrated to 5 mgÁmL À1 in 10 mM Hepes pH 7.4, 150 mM NaCl buffer.
Crystallization screening was carried out using the sittingdrop vapor diffusion method in 96-well plates at 22°C [17] . Octahedron shaped crystals with size~80 lm grew in 0.1 M Tris/HCl, pH8.5, and 2.0 M ammonium sulfate. The LRP6 PE1PE2 (UniProtKB/Swiss-Prot O75581, residues: 1-630) and LRP6 PE3PE4 (residues: 629-1244) [18] segments of the LRP6 ectodomain were cloned into the pNeo-sec vector [19] and the proteins were produced similarly from G418 (1 mgÁmL
) selected polyclonal stable cell lines.
Data collection and structure determination
Crystals were flash frozen by immersion in a reservoir solution supplemented with 25% (v/v) glycerol followed by transfer to liquid nitrogen. Datasets were recorded from crystals at 100 K with Pilatus 6M detector at Diamond Light Source (Didcot, UK, beamline I04 for Sulphur SAD and I03 for native) and processed with either HKL2000 or Xia2 (ref. [20, 21] ). Sulphur SAD datasets were collected at wavelength 1.70 A using inverse beam mode and merged with Xia2. HYSS was used to locate the sulfur sites which were then input to PHENIX AUTOSOL [22] for structure determination. The protein model was initially built with PHENIX AutoBuild [23] , further manually built with COOT [24] and finally refined with REFMAC [25] . The PYMOL Molecular Graphics System (Schr€ odinger, LLC, Cambridge, Cambridgeshire, UK) was used to prepare the figures.
SPR equilibrium binding studies
The LYPD6 LU (G46-A141) and its mutants (generated by two-step overlapping PCR) were cloned in a pHL-Avi3 vector [26] . The resulting protein has C-terminal Avi-His tag of sequence GTGGSGGSGLNDIFEAQIEWHEGRTKHHH HHH where the underlined sequence is the biotin ligase recognition site. This puts the expected LRP6 interaction site (NxI loop) at the opposite side of the attachment site so that no or little steric hindrance is expected. To create a LYP-D6 LU chimera with SOST NxI loop, LYPD6 LU residues 85-VTGNSI-90 were replaced with SOST residues 114-LLPNAI-119. Human LYPD6B (UniProtKB/Swiss-Prot Q8NI32, LYPD6B LU residues K40-S164) was cloned into the pHL-Avi3 vector. The LYPD6B LU mutant, LYPD6B NxI contains mutations R101N and T103I. To produce biotinylated proteins, the pHL-avi3 tagged plasmids were cotransfected with the pDisplay_BirA endoplasmic reticulum plasmid [27] into HEK293T cells with the media supplemented with 20 lM biotin. The procedure allows in vivo biotinylation to occur [27] , and the dialyzed conditional media was directly used for immobilization of ligands. The affinity between LYPD6 LU or its mutants or LYPD6B LU and LRP6 PE1PE2 or LRP6 PE3PE4 was measured at 25°C in 10 mM HEPES, pH 7.4, 150 mM NaCl and 0.005% Tween20 using a Biacore T100 machine (GE Healthcare, Little Chalfont, Buckinghamshire, UK). The biotinylated ligands were coupled to a streptavidin coated sensor chip, and the purified LRP6 PE1PE2 or LRP6 PE3PE4 proteins in two-fold serial dilution (from 10 lM to 5 nM) were used as analytes to flow through different ligand immobilized flow cells. The response was plotted versus the concentration of the analytes and fitted by nonlinear regression to a one site saturation binding model with equation f = B max 9 abs(x)/(K d + abs(x); Sigma Plot, Systat software, Inc., Hounslow, London, UK).
Results and Discussion
The LYPD6 LU domain shows a tri-fingered protein fold Human LYPD6 contains amino acid residues A23-L171 (residues M1-A22 constitute the signal peptide that is cleaved after maturation) and comprises only one LU domain and a C-terminal signal sequence for GPI anchorage (Fig. 1A) . To produce soluble protein suitable for crystallization, several constructs were tested and the construct of LYPD6 residues G46-A141 (LYPD6 LU ) was found to yield 0.5 mgÁL À1 of secreted, stable protein from HEK293S(GNTIÀ) cells. The purified deglycosylated LYPD6 LU protein was crystallized in a solution containing ammonium sulfate. The best crystal diffracted to high resolution (1.25 A). The structure was determined using the sulfur SAD method and has been refined to an R-factor and stereochemistry consistent with the high resolution of the data (Table 1) . There is one molecule in an asymmetric unit. The final structure contains all residues G46-A141 (Fig. 1A ) from the construct as well as amino acids 'ET' from the vector N-terminal cloning site and 'GT' from the C-terminal cloning site and 'LEVL' from the 3C protease cleavage site. All residues at the termini and in the loops are visible in the electron density. The overall flat hand-shaped LYP-D6 LU domain broadly conforms to the classical tri-fingered protein domain (TFPD) fold (Fig. 1A) . However, unlike all the known snake toxin TFPD fold containing proteins (as listed in ref [28] ), the first finger of LYPD6 LU is composed of an a-helix (a1) and a bstrand (b1), instead of two b strands. Finger 2 comprises a pair of antiparallel b-strands (b2, b3) and finger 3 is composed of a short a-helix (a2) and a pair of antiparallel b-strands (b4, b5). In addition to the basal three fingers, residues E123 to A141 form a long loop which shelters one side of the 'palm'. There are six disulfide bonds in total. Four of them (C49-C77, C70-C96, C102-C121, and C122-C127) form the tight network at the base of the palm commonly found in the conventional neurotoxin type TFPD fold [29, 30] . One additional disulfide bond (C51-C61) links a1 and b1 of finger 1 in LYPD6 LU ; this bond is only seen linking the secondary structure elements (two b strands) of finger 1 in nonconventional toxins [e.g., weak toxin (WTX) and cardiotoxin] and the Ly6 family of proteins, such as CD59, lynx1, and SLURP1 [29, 30] . The remaining disulfide bond in LYPD6 LU (C107-C118), which links the two b-strands (b4, b5) of finger 3, is distinctive; sequence analysis indicates it exists only in LYPD6, LYPD6B, and LYPD1 [30] .
LYPD6 is a glycoprotein with two predicted Nlinked glycosylation sites at N134 and N147. N147 was not included in our construct. The protein was produced in HEK293S(GNTIÀ) cells and treated with Endo F1; as expected from the Endo F1 cleavage reaction, only one GlcNAc is seen attached on N134 in the crystal structure (Fig. 1A) with weak but unambiguous density.
Structural comparison of LYPD6 LU to other members of the Ly family
The LYPD6 LU structure reveals a three fingered protein fold which is topologically similar to some snake venom neurotoxins, for example, Irditoxin from Boiga irregularis (PDB code: 2H7Z, 25% sequence identity, 67 Ca aligned at rmsd 3.1 A) [31] , WTX from Naja kaouthia (PDB code: 2MJ0, 16% sequence identity, 64 Ca aligned at rmsd 2.5 A) and b-cardiotoxin from Ophiophagus hannah (PDB code: 3PLC, 26% sequence identity, 58 Ca aligned at rmsd 2.4 A). This prototoxin (inactive, nontoxic precursor toxin) subgroup of trifingered proteins exists in a variety of organisms, from Drosophila to human. A Dali server [32] search for related structures identified Bucandin (PDB code: 1F94), a presynaptic snake neurotoxin from Bungarus candidus (Malayan krait) [33] , as closely related to LYPD6 LU (rmsd of 2.0 A for 59 equivalent Ca atoms with sequence identity of 10.7%). The structural superposition of LYPD6 LU with Bucandin is shown in Fig. 1C . Numbers in brackets refer to the highest resolution shell of data.
In the human genome, at least 45 gene products contain the trifingered protein domain [34] and among these 36 belong to the ly6/uPAR family [29] . Structure alignment with PDBeFold [35] identified that the transforming growth factor beta type II receptor (TbRII) ligand binding domain (PDB code 1KS6) [36] is the closest structural homolog of LYPD6 LU . Although the sequence identity is only 14%, the two structures can be superimposed with 76 equivalent Ca atoms and a rmsd of 2.2 A (Fig. 1D) . And the TbRII, together with Act-RIIA and BMP-RAI (PDB code 1BTE and 1REW, respectively) have an a-helix in their finger1. Both DALI and PDBeFold found similar hits, and lF94 and IKS6 are listed as the top hits in the two search engines.
The tip of LYPD6 LU finger 2 presents an exposed NxI motif
The crystal structure of LYPD6 LU reveals the distinctive, tripeptide, NxI motif exposed at the tip of finger 2 of the TFPD fold (Fig. 1B) . The NxI motif has been identified as a LRP5/6 (specifically LRP5/6 PE1PE2 ) binding motif required for function in the Wnt secreted inhibitors, SOST, WISE, and DKK [8, 9] . The LYPD6 LU NxI bearing surface area is a negatively charged stripe surrounded by positively charged patches ( Fig. 2A) . The potential binding surface of LRP6 PE1 for the NxI motif comprises a deep hydrophobic pocket for the isoleucine and a shallower, slightly positively charged pocket accommodating the asparagine. The two pockets are surrounded by an extended region of very strong negative charges on one side, and a stripe of positive charges on the other side (Fig. 4A ). LYPD6 exists in many species of vertebrate including humans, but not in the invertebrates Drosophila or Caenorhabditis elegans. The Nxl motif is conserved for mammalian LYPD6 sequences (Fig. 2B,  C) , but not for amphibians. In the zebrafish, the NxI motif isoleucine is replaced by a similar hydrophobic residue, valine. The zebrafish NxV motif may still be able to bind the LRP6 PE1PE2 , as an anti LRP6 PE1 antibody (YW210.09) bearing a NxV motif has been reported to bind at the same LRP6 PE1 site as the canonical NxI motif (PDB code: 3SOB) [8] . Consistent with this hypothesis, zebrafish LYPD6 has been reported to immunoprecipitate with LRP6 and function as a Wnt signaling enhancer not only in zebrafish but also in Xenopus [10] . Bourhis et al. [8] reported that mutation of the asparagine to alanine in the NxI motif abolishes binding; however, it remains to be seen if the Xenopus LYPD6 (which contains an ExV motif) can also bind to LRP6 and function as a Wnt signaling enhancer.
The LYPD6 NxI motif is essential for binding to LRP6 PE1PE2
We investigated the NxI motif's role in the interaction of LYPD6 LU and LRP6 PE1PE2 or LRP6 PE3PE4 by using surface plasmon resonance (SPR) to assay for binding. Biotinylated LYPD6 LU domain protein immobilized onto a streptavidin coated CM5 chip showed no measurable interaction with LRP6 PE3PE4 analyte (Fig. 3A) . In contrast, LPR6 PE1PE2 bound to LYPD6 LU with a K d of 0.79 lM (Fig. 3A) . LYPD6 belongs to a large family of LU domain proteins including LYPD 1-11, however, only LYPD6 has a NxI motif. LYPD6B has 55% sequence identity and 62% similarity to LYPD6, both are reported to modulate nAChR function [11, 12] , but similar to the other family members, LYPD6B lacks the NxI motif. Instead, LYPD6B has the sequence 'RxT', of which the arginine, in particular, is sterically incompatible with NxI type binding. Indeed we found no measurable binding between immobilized LYPD6B LU and LRP6 PE1PE2 analyte (Fig. 3A) . However, a mutated LYPD6B LU (LYPD6B NxI ), in which the 'RxT' is replaced by the NxI motif (Table 2) , gained some binding to LRP6 PE1PE2 , albeit weakly with a K d of 31 lM (Fig. 3A) . We proceeded to probe the contribution of the motif residues to binding. Mutations of the signature NxI motif residues impacted on the ability of LYPD6 LU to bind LRP6 PE1PE2 ; LYPD6 LU mutation N88A abolishes binding and I90E severely reduces binding to a K d of 19 lM (Fig. 3B, Table 2 ). These results are similar to those previously reported for the equivalent mutations of the NxI motif in DKK1 and SOST [8] Interestingly, the relative severity of the effect for the two mutations is reversed in LYPD6 LU compared to DKK1 and SOST, for both of which the isoleucine to glutamic acid substitution had the bigger effect on binding than the mutation of asparagine to alanine [8] . In contrast, mutation E111R, a prominently exposed residue chosen because it is located outside the NxI motif on a different finger (finger 3), does not affect the interaction (Fig. 3B) . These SPR data suggest that the NxI motif is crucial for the interaction of LYPD6 LU with the LRP6 PE1PE2 receptor, specifically the N-terminal LRP6 PE1PE2 segment, a characteristic resembling that of the secreted Wnt inhibitor SOST, which uses its NxI motif to bind LRP6 PE1PE2 , but not LRP6 PE3PE4 (ref. [8, 9] ).
In addition to the asparagine and isoleucine residues, the sequence surrounding the NxI motif has also been suggested to contribute to LRP6 binding in Wnt antagonists [8] . This conclusion is consistent with our finding that the creation of a NxI motif in the LYPD6B LU mutant R101N_T103I generates much weaker binding to LRP6 PE1PE2 than that we observe for LYPD6 LU . We therefore next asked whether the NxI motif containing loop of LYPD6 LU could be replaced with the corresponding loop of SOST. In LYPD6 LU , the finger 2 tip sequence is 84-EVTGNSI-90. We replaced VTGNSI six amino acids with the SOST loop sequence 114-LLPNAI-119 to generate a chimera (Table 2) . SPR binding assays showed the chimera is able to interact well with LRP6 PE1PE2 , with K d 0.89 lM, which is close to the level of binding shown by wild type LYPD6 (Fig. 3B, Table 2 ).
As both LYPD6 LU and SOST use the NxI motif to bind LRP6 PE1PE2, we superposed the NxI motif of LYPD6 LU with the equivalent region from the SOST peptide_LRP6 PE1 complex structure (PDB code 3SOV) [8] and the SOST apo structure (PDB code 2K8P) [37] ( Fig. 4A-C) . The conformation of the NxI motif of LYPD6 LU is similar to that of the apo SOST which is structurally different to the LRP6 bound SOST peptide. If the Cas of the NxI of LYPD6 LU are aligned with those of the bound SOST peptide, the asparagine side chains have a similar orientation, but the orientations of the isoleucine side chains differ by~100°( note that the isoleucine, I90, in our LYPD6 LU crystal structure is not involved in lattice contacts and has well-ordered electron density). If N88 and I90 of the NxI motif in our LYPD6 LU structure are docked into their putative binding pockets in LRP6 PE1 , finger 1 and finger 3 of LYPD6 clash with LRP6 PE1 . Similarly, the SOST apo structure also clashes with the LRP6 PE1 (Fig. 4A,B ) if N117 and I119 are simply docked into the binding pockets on LRP6 PE1 . The experimentally observed difference in the conformation of the NxI motif for apo SOST and LRP6 bound SOST peptide, alongside the steric clashes apparent in complexes modeled by simple docking of apo structures, suggest that conformational changes of the NxI motif are required for LRP6 binding. However, detailed analysis of the interactions between LYPD6 (or SOST) and LRP6 will require the structure(s) of the complex(es). It is noteworthy that although LYPD6 and SOST/ DKK bind the same site on LRP6, LYPD6 enhances Wnt signaling and SOST/DKK inhibit Wnt signaling (Fig. 4D,E) . SOST and DKK are secreted proteins, while LYPD6 is GPI anchored and has been reported to be preferentially localized to lipid rafts in the membrane [10] . The differences in the context in which these ligands bind LRP6 may contribute to the divergence in their effects on Wnt signaling.
Possible interaction area with nAChRs
LYPD6 has been shown to be able to bind multiple subtypes of nAChR [38] , including the a7 subtype, which was previously reported not able to bind LYPD6 (Ref. [11] ). Binding of LYPD6 to nAChRs results in attenuated nicotine-induced hippocampal inward currents [38] . The structure of LYPD6, or other TFPDs, in complex with nAChRs is not available. However, the structure of human a7 AChR chimeric with aceytylcholine binding protein in complex with the TFPD family member a-bungarotoxin (a-btx) has been reported (PDB code: 4HQP) [39] . a-btx uses its finger 2 tip to interact with a7 nAChR, and can compete with LYPD6 for binding [38] . However, unlike a-btx, the LYPD6 finger 2 loop does not form an a-helix, and lacks the phenylalanine and arginine residues which a-btx uses to interact with a7 nAChR. Since both LYPD6 and LYPD6B interact with nAChRs, and their LU domains have amino acid identity of 45% (Fig. 5A) , we modeled the LYPD6B LU structure with SWISS-MODEL [40] using LYPD6 LU as template, and looked for sequence conservation of residues exposed on the three fingers of the LYPD6 LU structure. While most of the prominent surface The mutated residues are indicated in red color. The visible residues in the X-ray complex structures of DKK1 and SOST are underlined. The NxI motif or equivalent residues are in bold.
residues on finger 2 and finger 3 of LYPD6 LU are not conserved in LYPD6B LU (Fig. 5A) , residues D57, Y57, R63, and W64 in the distinctive finger 1 helix of LYPD6 are exposed and conserved in LYPD6B (equivalent residues, D70, Y72, R77, W78, Fig. 5B ). We then modeled the a7 nAChR-LYPD6 LU complex (Fig. 4C) , with HADDOCK2.2 webserver [41] . The top HADDOCK scored (À83.3 AE 8.5, arbitrary units) model is shown in Fig. 5C . The model has Van der Waals energy À41.7 AE 4.2 kcalÁmol À1 and electrostatic energy À104.4 AE 14.4 kcalÁmol À1 . The rmsd from the overall lowest energy structure is 0.9 AE 0.6 A. All four residues (Fig. 5B) conserved between LYPD6 LU and LYPD6B LU in finger 1 are involved in interactions in the modeled complex. We therefore speculate that these residues may be involved in the interaction of LYPD6 or LYPD6B with nAChRs.
Conclusion
The high resolution crystal structure of the LYPD6 LU shows a trifingered protein fold with a distinctive ahelix in finger 1 and a NxI motif prominently displayed at the tip of finger 2. Among members of the large Ly6/uPAR family, only LYPD6 possesses the NxI motif, which is crucial for the LRP6 PE1PE2 Fig. 4 . Predicted interactions between LYPD6 and LRP6. (A) The LYPD6 LU (cyan ribbon) and apo SOST (gray ribbon, PDB code 2K8P) [37] are docked on the surface of LRP6 PE1 by overlapping C a atoms of the NxI motif with the corresponding atoms of the SOST peptide_LRP6 PE1 complex (PDB code 3SOV) [8] . LRP6 PE1 is shown as electrostatic surface and the bound SOST peptide as purple sticks. binding activity. SPR binding assays reveal LYPD6 LU can interact with LRP6 PE1PE2 but not LRP6 PE3PE4 . The closely related family member LYPD6B LU does not interact with LRP6 PE1PE2 , but on mutation to generate a NxI motif gains binding capability to LRP6 PE1PE2. Mutation of the NxI motif of LYPD6 LU abolishes or severely reduces the LRP6 PE1PE2 interaction. When the LYPD6 LU finger 2 loop is replaced by the NxI containing loop of SOST, the chimera can still interact with LRP6 PE1PE2 . In combination, the results from our structure guided mutagenesis and SPR binding assays reveal that the NxI motif plays a key role in the interaction of LYPD6 with LRP6. Hereto, NxI motif-mediated binding to the LRP6 PE1PE2 segment of the LRP6 ectodomain has been characteristic of secreted antagonists of Wnt signaling, such as SOST, DKK, and WISE. It is notable that NxI mediated binding by the GPI anchored LYPD6 receptor results in enhancement in Wnt signaling [10] . This is an intriguing divergence in outcome from a structurally similar interaction. Further investigation is required to provide insight into the factors and mechanisms that determine the balance between the enhancer and antagonist functions of NxI mediated binding in Wnt signaling.
Accession codes
Coordinates and structure factors have been deposited in the Protein Data Bank under accession code 6GBI. Comparison of the structures of LYPD6 LU (cyan) and the modeled LYPD6B LU (magenta). The surface exposed residues in finger 1 common to both proteins are shown as sticks. (C) Superposition of a putative LYPD6-a7-nAChR complex obtained by docking and the experimentally determined a-Bgtxa7-nAChR complex (PDB code 4HQP [39] ). a7-nAChR is shown in gray, LYPD6 in cyan and a-Bgtx in yellow.
